Updated Jul 16, 2026
Lebovits Chaim has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $11K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | BCLI | BRAINSTORM CELL THERAPEUTICS INC. | A — Grant or award | 1.80M | $0.00 | |
| 2024-10-02 | BCLI | BRAINSTORM CELL THERAPEUTICS INC. | P — Open-market purchase | 1.8K | $3.43 | $6K |
| 2024-10-02 | BCLI | BRAINSTORM CELL THERAPEUTICS INC. | P — Open-market purchase | 22.0K | $0.23 | $5K |
Lebovits Chaim is a corporate insider — currently tracked as President & CEO of BRAINSTORM CELL THERAPEUTICS INC. (BCLI). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($11K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lebovits Chaim profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.